The State Administration for Market Regulation unconditionally approved the case in which Shanghai Yun Health acquired the equity stakes of 18 companies.

Mars Finance News: On July 28, the State Administration for Market Regulation released the list of unconditional approvals for operator concentration cases from July 13, 2026 to July 19, 2026. The list includes Shanghai Pharmaceutical Group Health & Wellness Cloud Commerce Co., Ltd.’s acquisition of the equity of 18 companies, including Shanghai Pharma-Youxin Big Pharmacy (Huimin) Co., Ltd., as well as Hangyang Group Co., Ltd.’s establishment of a new joint venture with Shandong Haili Chemical Co., Ltd., among others. (State Administration for Market Regulation website)
SH PHARMA-1.08%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned